
Tara L. Martinez
Examiner (ID: 12501)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 718 |
| Issued Applications | 367 |
| Pending Applications | 92 |
| Abandoned Applications | 264 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18177791
[patent_doc_number] => 20230038520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => THERAPEUTIC ADENO-ASSOCIATED VIRUS COMPRISING LIVER-SPECIFIC PROMOTERS FOR TREATING POMPE DISEASE AND LYSOSOMAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/778175
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778175
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778175 | THERAPEUTIC ADENO-ASSOCIATED VIRUS COMPRISING LIVER-SPECIFIC PROMOTERS FOR TREATING POMPE DISEASE AND LYSOSOMAL DISORDERS | Nov 18, 2020 | Pending |
Array
(
[id] => 18019005
[patent_doc_number] => 20220370504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD FOR THE PRODUCTION OF MULLER CELLS AND CELL PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/773103
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773103 | METHOD FOR THE PRODUCTION OF MULLER CELLS AND CELL PRODUCT | Oct 29, 2020 | Pending |
Array
(
[id] => 18077390
[patent_doc_number] => 20220403002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => B-CELL ANTIBODY RECEPTOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/773241
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773241 | B-CELL ANTIBODY RECEPTOR AND USE THEREOF | Oct 27, 2020 | Pending |
Array
(
[id] => 18020941
[patent_doc_number] => 20220372440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD FOR PRODUCING T CELLS HAVING CELL SURFACE MARKERS OF CD45RA+ AND CCR7+
[patent_app_type] => utility
[patent_app_number] => 17/772476
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772476 | METHOD FOR PRODUCING T CELLS HAVING CELL SURFACE MARKERS OF CD45RA+ AND CCR7+ | Oct 26, 2020 | Abandoned |
Array
(
[id] => 18109866
[patent_doc_number] => 20230002746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => BASE-EDITING SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/772106
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772106 | BASE-EDITING SYSTEMS | Oct 19, 2020 | Pending |
Array
(
[id] => 17945775
[patent_doc_number] => 20220332792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/639962
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639962 | ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF | Sep 2, 2020 | Pending |
Array
(
[id] => 17830469
[patent_doc_number] => 20220267773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => Targeted RNA cleavage with CRISPR-Cas
[patent_app_type] => utility
[patent_app_number] => 17/628913
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -86
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628913 | Targeted RNA cleavage with CRISPR-Cas | Jul 22, 2020 | Pending |
Array
(
[id] => 18036586
[patent_doc_number] => 20220380801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => TRIPARTITE SYSTEMS FOR PROTEIN DIMERIZATION AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/627210
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627210 | TRIPARTITE SYSTEMS FOR PROTEIN DIMERIZATION AND METHODS OF USE | Jul 14, 2020 | Pending |
Array
(
[id] => 18142088
[patent_doc_number] => 20230015932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHOD OF GENERATION OF LYMPHO-MYELOID NICHES
[patent_app_type] => utility
[patent_app_number] => 17/786188
[patent_app_country] => US
[patent_app_date] => 2020-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786188
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786188 | METHOD OF GENERATION OF LYMPHO-MYELOID NICHES | Jul 4, 2020 | Pending |
Array
(
[id] => 17790036
[patent_doc_number] => 20220249127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHOD FOR ADMINISTERING ONCOLYTIC VIRUS TO TUMOR TISSUE, AND DEVICE FOR ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/610925
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610925 | METHOD FOR ADMINISTERING ONCOLYTIC VIRUS TO TUMOR TISSUE, AND DEVICE FOR ADMINISTRATION | May 13, 2020 | Pending |
Array
(
[id] => 17595678
[patent_doc_number] => 20220145252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHODS FOR MANUFACTURING T CELLS EXPRESSING OF CHIMERIC ANTIGEN RECEPTORS AND OTHER RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/599786
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599786 | METHODS FOR MANUFACTURING T CELLS EXPRESSING OF CHIMERIC ANTIGEN RECEPTORS AND OTHER RECEPTORS | Mar 29, 2020 | Pending |
Array
(
[id] => 17671060
[patent_doc_number] => 20220184227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => MUTATED ADENO-ASSOCIATED VIRUS CAPSID PROTEINS, AAV PARTICLE COMPRISING THE SAME AND LIVER DIRECTED AAV VECTOR GENE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/599235
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599235 | MUTATED ADENO-ASSOCIATED VIRUS CAPSID PROTEINS, AAV PARTICLE COMPRISING THE SAME AND LIVER DIRECTED AAV VECTOR GENE THERAPY | Mar 29, 2020 | Pending |
Array
(
[id] => 17702950
[patent_doc_number] => 20220202956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => ADENO-ASSOCIATED VIRUS DELIVERY OF CLN6 POLYNUCLEOTIDE
[patent_app_type] => utility
[patent_app_number] => 17/426993
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426993 | ADENO-ASSOCIATED VIRUS DELIVERY OF CLN6 POLYNUCLEOTIDE | Feb 3, 2020 | Pending |
Array
(
[id] => 18195498
[patent_doc_number] => 20230049017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => DIFFERENTIATION METHOD FOR PROCURING LARGE AMOUNT OF CELLS BY CHOPPING 3D ORGANOIDS PREPARED FROM HUMAN PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/758696
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758696
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758696 | DIFFERENTIATION METHOD FOR PROCURING LARGE AMOUNT OF CELLS BY CHOPPING 3D ORGANOIDS PREPARED FROM HUMAN PLURIPOTENT STEM CELLS | Jan 12, 2020 | Pending |
Array
(
[id] => 17386005
[patent_doc_number] => 20220033857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => EDITING OF HAEMOGLOBIN GENES
[patent_app_type] => utility
[patent_app_number] => 17/278679
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278679 | EDITING OF HAEMOGLOBIN GENES | Sep 24, 2019 | Pending |
Array
(
[id] => 17383907
[patent_doc_number] => 20220031759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => COMPOSITION FOR SKIN REGENERATION AND WOUND HEALING, COMPRISING INDUCED EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/276270
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276270 | COMPOSITION FOR SKIN REGENERATION AND WOUND HEALING, COMPRISING INDUCED EXOSOMES | Sep 18, 2019 | Abandoned |